The increase in MCT4 expression is associated with clinical manifestations and may play an important role in the progression of the disease to the late stage or the enhancement of cancer cell invasion (Choi et al., 2016[4], 2018[5]; Hao et al., 2010[15]; Pertega-Gomes et al., 2011[18]). Here, SLC16A3 is linked to cancer.